Skip to main content
Premium Trial:

Request an Annual Quote

IsoPlexis Inks Swiss Distribution Deal With Bucher Biotech

NEW YORK – Single-cell proteomics firm IsoPlexis said Tuesday it has entered into an exclusive agreement with Swiss life science tools distributor Bucher Biotec.

The agreement will allow Branford, Connecticut-based IsoPlexis to expand sales of its IsoLight and IsoSpark proteomics platforms into Switzerland.

The deal adds to recent agreements IsoPlexis has inked for distribution in countries including Singapore, Malaysia, China, Taiwan, Japan, South Korea, Spain, and Portugal.

"We are excited to partner with Bucher Biotec to further expand the reach of our unique solutions," Peter Siesel, IsoPlexis' chief commercial officer, said in a statement. "Our functional proteomics platform accelerates the development of personalized, curative medicines across a range of diseases and research disciplines. With this partnership, we are excited to see our usership grow even further."

Financial and other terms of the agreement were not disclosed.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Gene Linked to Alkaline Sensitivity in Plants Identified

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.